Literature DB >> 20501806

Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer.

Soichiro Yamamura1, Kazumori Kawakami, Hiroshi Hirata, Koji Ueno, Sharanjot Saini, Shahana Majid, Rajvir Dahiya.   

Abstract

The secreted Frizzled-related proteins (sFRP) are modulators of the Wnt signaling pathway, which is involved in embryonic development and tumor progression. The functions of sFRP2 have not been studied in renal cancer. Transient transfection of sFRP2 promoted cell growth in renal carcinoma cells, whereby the largest effect was observed in A498 cells. To further study the functions of sFRP2 gene in renal carcinoma cells, we established A498 renal cancer cell lines, which stably expressed sFRP2. Stably expressed sFRP2 significantly promoted cell proliferation in vitro and in vivo tumor growth. The stably expressed sFRP2 cells were also found to have reduced UV-induced apoptosis and increased G(2) phase of the cell cycle. The phosphorylation level at Ser(33/37)/Thr(41) of beta-catenin was lower in the stable sFRP2 cell lines compared with the control cell line. sFRP2 significantly activated T-cell factor/lymphoid enhancer factor transcriptional activity. In the stable sFRP2 cell line, expression of c-Fos, Bcl2, Bcl-w, cyclin B2, and cyclin E2 genes was significantly increased and p53 expression was decreased. This is the first report documenting that sFRP2 activates the canonical Wnt pathway and promotes cell growth by evoking diverse signaling cascades in renal cancer cells. This study may provide better strategies for the management of renal cancer through regulation of sFRP2 pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501806     DOI: 10.1158/1535-7163.MCT-10-0012

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  26 in total

1.  Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.

Authors:  Xiao-Wen Hao; Sheng-Tao Zhu; Yuan-Long He; Peng Li; Yong-Jun Wang; Shu-Tian Zhang
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

2.  Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis.

Authors:  Yuri K Peterson; Patrick Nasarre; Ingrid V Bonilla; Eleanor Hilliard; Jennifer Samples; Thomas A Morinelli; Elizabeth G Hill; Nancy Klauber-DeMore
Journal:  Angiogenesis       Date:  2017-08-24       Impact factor: 9.596

3.  P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.

Authors:  M Batisse-Lignier; I Sahut-Barnola; F Tissier; T Dumontet; M Mathieu; C Drelon; J-C Pointud; C Damon-Soubeyrand; G Marceau; J-L Kemeny; J Bertherat; I Tauveron; P Val; A Martinez; A-M Lefrançois-Martinez
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

4.  Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins.

Authors:  Krista Marie Vincent; Lynne-Marie Postovit
Journal:  J Cell Commun Signal       Date:  2017-06-07       Impact factor: 5.782

5.  Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.

Authors:  Denise Garcia; Patrick Nasarre; Ingrid V Bonilla; Eleanor Hilliard; Yuri K Peterson; Laura Spruill; Anne-Marie Broome; Elizabeth G Hill; Jason T Yustein; Shikhar Mehrotra; Nancy Klauber-DeMore
Journal:  Ann Surg Oncol       Date:  2019-09-12       Impact factor: 5.344

Review 6.  The complex roles of Wnt antagonists in RCC.

Authors:  Sharanjot Saini; Shahana Majid; Rajvir Dahiya
Journal:  Nat Rev Urol       Date:  2011-10-25       Impact factor: 14.432

7.  A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.

Authors:  Emily Fontenot; Emma Rossi; Russell Mumper; Stephanie Snyder; Sharareh Siamakpour-Reihani; Ping Ma; Eleanor Hilliard; Bradley Bone; David Ketelsen; Charlene Santos; Cam Patterson; Nancy Klauber-DeMore
Journal:  Mol Cancer Ther       Date:  2013-04-19       Impact factor: 6.261

8.  Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.

Authors:  James D West; Eric D Austin; Christa Gaskill; Shennea Marriott; Rubin Baskir; Ganna Bilousova; Jyh-Chang Jean; Anna R Hemnes; Swapna Menon; Nathaniel C Bloodworth; Joshua P Fessel; Johnathan A Kropski; David Irwin; Lorraine B Ware; Lisa Wheeler; Charles C Hong; Barbara Meyrick; James E Loyd; Aaron B Bowman; Kevin C Ess; Dwight J Klemm; Pampee P Young; W David Merryman; Darrell Kotton; Susan M Majka
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

9.  Decreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemia.

Authors:  Hong Guo; Jiang Lin; Xiang-Mei Wen; Jing Yang; Wei Qian; Zhao-Qun Deng; Ji-Chun Ma; Chun-Yan Tang; Cui An; Qing Liu; Hong Zhou; Jun Qian
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

10.  Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.

Authors:  Huensuk Kim; Seungyeul Yoo; Ruoji Zhou; An Xu; Jeffrey M Bernitz; Ye Yuan; Andreia M Gomes; Michael G Daniel; Jie Su; Elizabeth G Demicco; Jun Zhu; Kateri A Moore; Dung-Fang Lee; Ihor R Lemischka; Christoph Schaniel
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.